Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
118F-dopamine
(D00633)		----[1] 6 💬
2A-dopamine
(D00633)		----[1] 6 💬
3Allogenic embryonic stem CELL-derived A9 dopamine progenitor cell (A9-DPC) high dose
(D00633)		----[1] 6 💬
4Allogenic embryonic stem CELL-derived A9 dopamine progenitor cell (A9-DPC) LOW dose
(D00633)		----[1] 6 💬
5Allogenic embryonic stem cellderived A9 dopamine progenitor cell (A9-DPC)_high dose
(D00633)		----[1] 6 💬
6Allogenic embryonic stem cellderived A9 dopamine progenitor cell (A9-DPC)_low dose
(D00633)		----[1] 6 💬
7Autologous midbrain dopamine neurons
(D00633)		----[1] 6 💬
8Bromocriptine and other dopamine agonists
(D00633)		[1] Bromocriptine[2] Bromocriptine mesylate ,
Bromocriptine 💬 		[2] DRD2,
PRL 💬 		[14] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
9Cerebral dopamine neurotrophic factor
(D00633)		[1] HER-902---[1] 6 💬
10Combination with dopamine agonist cabergoline
(D00633)		----[1] 77 💬
11Continuous release dopamine agonists
(D00633)		----[1] 6 💬
12Dopamine
(D00633)		[1] Dopamine[2] Dopamine hydrochloride (D00633),
Dopamine 💬 		[5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		[13] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[3] 6, 7, 77 💬
13Dopamine agent
(D00633)		[1] Dopamine[2] Dopamine hydrochloride (D00633),
Dopamine 💬 		[5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		[13] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
14Dopamine agonist treatment
(D00633)		[1] Dopamine[2] Dopamine hydrochloride (D00633),
Dopamine 💬 		[5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		[13] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 74 💬
15Dopamine agonists
(D00633)		[1] Dopamine[2] Dopamine hydrochloride (D00633),
Dopamine 💬 		[5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		[13] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 74 💬
16Embryonic dopamine cell implant surgery
(D00633)		----[1] 6 💬
17Recombinant human cerebral dopamine neurotrophic factor
(D00633)		[1] HER-902---[1] 6 💬
18Role OF dopamine
(D00633)		----[1] 6 💬
19Solution DE chlorhydrate DE dopamine ANAérobie
(D00633)		----[1] 6 💬